Skip to content
★ Sign in to follow
BH

Brook H. Byers

Executive
CareDx, Inc.Pacific Biosciences of California, Inc.Genomic Health IncFoundation Medicine, Inc.Veracyte, Inc.
Total declarations
71
Companies
5
▲ Purchases (2 ops.)
€396k
▼ Sales (0 ops.)
—

Latest filing published 06 Jul 2016 for CareDx, Inc..

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 23 Jul 2014 · 4491 days ago · €3,906
    -32.4%
    Entry US$10.00 · Close at T+365 US$6.76

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Brook H. Byers: trading record in brief

Brook H. Byers discloses dealings in 5 companies, chiefly Foundation Medicine, Inc., CareDx, Inc. and Pacific Biosciences of California, Inc. The record holds 71 filings, for trades running from 9 December 2010 to 1 July 2016.

On the market, this insider has only ever bought: 2 purchases, €396k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 9 share grants.

On 6 July 2016 came the latest disclosure, a share grant in CareDx, Inc. The clock since the last published purchase (23 July 2014) now reads 4,491 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Brook H. Byers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations64 total

25 of 64 declarations